Functional histamine H-3 and adenosine A(2A) receptor heteromers in recombinant cells and rat striatum


Por: Márquez-Gómez R., Robins M.T., Gutiérrez-Rodelo C., Arias J.-M., Olivares-Reyes J.-A., Rijn R.M., Arias-Montaño J.-A.

Publicada: 1 mar 2018
Categoría: Pharmacology

Resumen:
In the striatum, histamine H-3 receptors (H(3)Rs) are co-expressed with adenosine A(2A) receptors (A(2A)Rs) in the cortico-striatal glutamatergic afferents and the GABAergic medium-sized spiny neurons that originate the indirect pathway of the basal ganglia. This location allows H(3)Rs and A(2A)Rs to regulate the striatal GABAergic and glutamatergic transmission. However, whether these receptors can physically interact has not yet been assessed. To test this hypothesis, a heteromer-selective in vitro assay was used to detect functional complementation between a chimeric A(2A) R-302-G alpha(qi4) and wild-type H(3)Rs in transfected HEK-293T cells. H3R activation with the agonist RAMH resulted in Ca2+ mobilization (pEC(50) 7.31 +/- 0.23; maximal stimulation, Emax 449 +/- 25% of basal) indicative of receptor heterodimerization. Functional H3R-A(2A)R heteromers were confirmed by co-immunoprecipitation and observations of differential CAMP signaling when both receptors were co-expressed in the same cells. In membranes from rat striatal synaptosomes, H3R activation decreased A(2A)R affinity for the agonist CGS-21680 (pKi values 8.10 +/- 0.04 and 7.70 +/- 0.04). Moreover, H(3)Rs and A(2A)Rs co-immunoprecipitated in protein extracts from striatal synaptosomes. These results support the existence of a H3R-A(2A)R heteromer with possible physiological implications for the modulation of the intra-striatal transmission. (C) 2017 Elsevier Ltd. All rights reserved.

Filiaciones:
Márquez-Gómez R.:
 Departamento de Fisiología, Biofísica y Neurociencias, Cinvestav-IPN, Av. IPN 2508, Zacatenco, 07360 Ciudad de México, Mexico

Robins M.T.:
 Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, USA

Gutiérrez-Rodelo C.:
 Departamento de Bioquímica, Cinvestav-IPN, Av. IPN 2508, Zacatenco, 07360 Ciudad de México, Mexico

Arias J.-M.:
 Programa de Neurociencias-UIICSE, Facultad de Estudios Superiores Iztacala, UNAM, Av. de los Barrios 1, Los Reyes Iztacala, 54090 Estado de México, Mexico

Olivares-Reyes J.-A.:
 Departamento de Bioquímica, Cinvestav-IPN, Av. IPN 2508, Zacatenco, 07360 Ciudad de México, Mexico

Rijn R.M.:
 Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, USA

Arias-Montaño J.-A.:
 Departamento de Fisiología, Biofísica y Neurociencias, Cinvestav-IPN, Av. IPN 2508, Zacatenco, 07360 Ciudad de México, Mexico
ISSN: 10961186
Editorial
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND, Estados Unidos America
Tipo de documento: Article
Volumen: 129 Número:
Páginas: 515-525
WOS Id: 000428102600048
ID de PubMed: 29217157